Supplemental Figure 2B from A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non–Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1

Autor: Harriet M. Kluger, Michael Hurwitz, Mario Sznol, Scott Gettinger, William Damsky, Curtis J. Perry, Susan M. Kaech, Marcus Bosenberg, Ovid Trifan, Amit Mahajan, Wei Wei, Daniel Zelterman, Gail Anderson, Neta Shanwetter Levit, Barbara Johnson, Amanda Ralabate, Lucia Jilaveanu, Lin Zhang, Irina Krykbaeva, Shlomit Jessel, Dijana Djureinovic, Sarah A. Weiss
Rok vydání: 2023
Popis: Association between pre-treatment CD4+ T-cell density from available baseline tumor tissue (n=14) and the duration of time on treatment in days.
Databáze: OpenAIRE